Results 51 to 60 of about 1,334 (146)

Switching to faricimab from the current anti-VEGF therapy: evidence-based expert recommendations

BMJ Open Ophthalmology
Dual inhibition of the angiopoietin (Ang)/Tie and vascular endothelial growth factor (VEGF) signalling pathways in patients with retinal diseases, such as neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME), may induce ...
Sanjay Sharma, David T Wong, Shaheer Aboobaker, David Maberley, Pradeepa Yoganathan   +4 more
doaj   +1 more source

Safety Evaluation of Bilateral Same-Day Intravitreal Injection of Faricimab

Ophthalmology and Therapy
Introduction Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is the most commonly performed ophthalmic procedure. Many retinal specialists routinely perform same-day bilateral intravitreal anti-VEGF injections, in order to
Michael D. Karampelas, Irini P. Chatziralli, Dimitrios A. Karagiannis   +2 more
doaj   +1 more source

Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis

BMJ Open Ophthalmology
Objective To evaluate the efficacy and safety of faricimab compared with other anti-vascular endothelial growth factor (anti-VEGF) agents in treating neovascular age-related macular degeneration (nAMD) patients.Methods and analysis A systematic review ...
Francisco Rodríguez, Daniel Samacá-Samacá, Claudia Hernández-Castillo, Laura Prieto-Pinto, Carolina Sardi, Hugo Ocampo, Joshua Kock, Fabián Hernández   +7 more
doaj   +1 more source

Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Colombia

Journal of Health Economics and Outcomes Research
# Background Retinal diseases are major contributors to disability, significantly affecting patients' quality of life. Diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) represent a significant disease and economic ...
Daniel Samacá-Samacá, Antonio Robles, Hugo Ocampo, Francisco J. Rodríguez, Carolina Sardi-Correa, Laura Prieto-Pinto, Christian Bührer, Camilo Tamayo, David Rodríguez, Mauricio Hernández-Quintana   +9 more
doaj   +1 more source

Recurrent uveitic macular edema managed with intravitreal faricimab injection

Journal of Ophthalmic Inflammation and Infection
Purpose To present a case of recurrent uveitic macular edema (UME) treated with intravitreal faricimab injection. Methods Single case report from a tertiary referral center. Observations A 63-year-old Caucasian female presenting with recurrent UME due to
Negin Yavari, Dalia El Feky, Frances A. Anover, Khiem Nguyen, Azadeh Mobasserian, Quan Dong Nguyen, Christopher Or   +6 more
doaj   +1 more source

Dynamics of Treatment Response to Faricimab for Diabetic Macular Edema

Bioengineering
This study analyzes the dynamics of short-term treatment response to the first intravitreal faricimab injection in eyes with diabetic macular edema (DME). This retrospective, single-center, clinical trial was conducted at the Department of Ophthalmology,
Katrin Fasler, Daniel R. Muth, Mariano Cozzi, Anders Kvanta, Magdalena Rejdak, Frank Blaser, Sandrine A. Zweifel   +6 more
doaj   +1 more source

Sterile Intraocular Inflammation Associated With Faricimab

JAMA Ophthalmology
ImportanceRandomized clinical trials are conducted to establish both drug safety and efficacy. However, evidence of adverse events associated with these drugs in the clinical practice setting can be of value at generating hypotheses regarding less common safety issues, even if causality cannot be determined.ObjectiveTo present and analyze cases of ...
Cozzi, Mariano, Ziegler, Alexander, Fasler, Katrin, Muth, Daniel Rudolf, Blaser, Frank, Zweifel, Sandrine Anne   +5 more
openaire   +3 more sources

Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography

Pharmaceutics
Our study aimed to assess the anatomical changes in the retina, including the assessment of the reduction of diabetic macular edema (DME) on optical coherence tomography (OCT) and the improvement of retinal microvascular parameters, defined by the ...
Dorota Śpiewak, Łukasz Drzyzga, Mariola Dorecka, Katarzyna Witek, Dorota Wyględowska-Promieńska   +4 more
doaj   +1 more source

Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review

International Journal of Retina and Vitreous
Background To systematically review the real-world outcomes of intravitreal faricimab treatment in patients with neovascular age-related macular degeneration (nAMD) to evaluate its efficacy and safety in clinical settings. This study was conducted due to
Nasratullah Nasimi, Safiullah Nasimi, Jakob Grauslund, Anna Stage Vergmann, Yousif Subhi   +4 more
doaj   +1 more source

Analysis of Choriocapillaris Reperfusion Topography following Faricimab Treatment for Neovascular Age-Related Macular Degeneration in Non-Treatment-Naïve Patients

Diagnostics
To assess changes in choriocapillaris (CC) vascular density surrounding macular neovascularization (MNV) in age-related macular degeneration (AMD) when transitioning from various anti-VEGF treatments to faricimab, using optical coherence tomography ...
Max Brinkmann, Pasquale Viggiano, Giacomo Boscia, Mathis Danckwardt, Evelyn Susantija, Tom Müller, Niccolò Castellino, Jakob Schweighofer, Francesco Boscia, Mario Damiano Toro, Yosuf El-Shabrawi   +10 more
doaj   +1 more source